These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 19672226)
1. [Use of omaron in patients with post-stroke cognitive disorders]. Parfenov VA; Belavina GR; Vakhnina NV; Gusev VV; Levin IaI; Markin SP; Starchina IuA Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(6):41-5. PubMed ID: 19672226 [TBL] [Abstract][Full Text] [Related]
2. [Omaron in the rehabilitation of post stroke outpatients]. Chuprina SE Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(6):54-7. PubMed ID: 20559275 [TBL] [Abstract][Full Text] [Related]
3. [Omaron in the treatment of vertebrobasilar insufficiency]. Lobzin SV; Bodrova TV; Vasilenko AV Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(1):40-3. PubMed ID: 19156085 [TBL] [Abstract][Full Text] [Related]
4. [Omaron in the restorative treatment of patients with chronic cerebrovascular insufficiency]. Stroganova IM; Kiparisov MA Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(1):70-2. PubMed ID: 20443242 [No Abstract] [Full Text] [Related]
5. [Omaron in the complex treatment of patients with multiple sclerosis]. Popova NF; Kamchatnov PR; Riabukhina OV; Batysheva TT; Zaĭtsev KA; Boĭko AN Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(11 Pt 1):17-20. PubMed ID: 21183917 [TBL] [Abstract][Full Text] [Related]
6. [Efficacy of acatinol memantine in mild cognitive disorder]. Levin OS; Iunishchenko NA; Dudarova MA Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7):36-42. PubMed ID: 19672236 [TBL] [Abstract][Full Text] [Related]
7. [The use of lucetam for improvement of cognitive functions in chronic cerebrovascular insufficiency (clinical and encephalographic study)]. Bugrova SG; Novikov AE Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(4):44-8. PubMed ID: 18379503 [TBL] [Abstract][Full Text] [Related]
8. [Phezam in combined therapy of ischemic stroke]. Arabkhanova MA; Pyshkina LI; Kabanov AA; Kolesnikova TI; Iasamanova AN; Martynov MIu; Gusev EI Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(2):24-6. PubMed ID: 18646379 [No Abstract] [Full Text] [Related]
9. [The results of using lucetam in patients with moderate cognitive impairment of different genesis]. Batysheva TT; Otcheskaia OV; Nesterova ON; Lisinker LN; Bobina LA; Ismailov AM; Shekkhirimov RK; Zhuravleva EIu; Kamchatnov PR; Boĭko AN Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):63-5. PubMed ID: 19255983 [No Abstract] [Full Text] [Related]
10. Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study. Pytel J; Nagy G; Tóth A; Spellenberg S; Schwarz M; Répassy G Clin Ther; 2007 Jan; 29(1):84-98. PubMed ID: 17379049 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of akatinol memantine in moderate cognitive impairments. Levin OS; Yunishchenko NA; Dudarova MA Neurosci Behav Physiol; 2010 Oct; 40(8):926-33. PubMed ID: 20683775 [TBL] [Abstract][Full Text] [Related]
12. [Approaches to the therapy of neurological presentations in diabetes mellitus]. Baratsevich ER; Posokhina OV Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(4):63-6. PubMed ID: 20517213 [TBL] [Abstract][Full Text] [Related]
13. [Efficacy and tolerability of choline alphoscerate (cereton) in patients with Parkinson's disease with cognitive disorders]. Levin OS; Batukaeva LA; Anikina MA; Iunishchenko NA Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(11):42-6. PubMed ID: 20032953 [TBL] [Abstract][Full Text] [Related]
14. [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia]. Tariska P; Paksy A Orv Hetil; 2000 May; 141(22):1189-93. PubMed ID: 10853348 [TBL] [Abstract][Full Text] [Related]
15. [Neuromidin in the treatment of cognitive impairment in the early rehabilitation period of ischemic stroke]. Pustokhanova LV; Morozova EM; Selivokhina OI; Shiliaeva EA Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(3 Pt 2):47-52. PubMed ID: 23612399 [TBL] [Abstract][Full Text] [Related]
16. [Noopept in the treatment of mild cognitive impairment in patients with stroke]. Amelin AV; Iliukhina AIu; Shmonin AA Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(10 Pt 1):44-6. PubMed ID: 22500312 [TBL] [Abstract][Full Text] [Related]
17. [Cognitive functions and treatment of their impairment in elderly patients with the vertebrobasilar issufficiensy]. Skoromets AA; Aliev KT; Lalayan TV; Pugachova EL; Smolko DG Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(4):18-24. PubMed ID: 23739435 [TBL] [Abstract][Full Text] [Related]
18. [Memantine (akatinol) therapy of cognitive impairment in Parkinson's disease complicated by dementia]. Litvinenko IV; Odinak MM; Mogil'naia VI; Perstenev SV Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(10):37-42. PubMed ID: 19008850 [TBL] [Abstract][Full Text] [Related]
19. The NeuroAiD II (MLC901) in vascular cognitive impairment study (NEURITES). Chen CL; Ikram K; Anqi Q; Yin WT; Chen A; Venketasubramanian N; Cerebrovasc Dis; 2013; 35 Suppl 1():23-9. PubMed ID: 23548916 [TBL] [Abstract][Full Text] [Related]
20. Experience in the use of Actovegin in the treatment of patients with cognitive disorders in the acute period of stroke. Derev'yannykh EA; Bel'skaya GN; Knoll EA; Krylova LG; Popov DV Neurosci Behav Physiol; 2008 Oct; 38(8):873-5. PubMed ID: 18802768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]